SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010406
Filing Date
2021-08-05
Accepted
2021-08-05 08:02:17
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20210630x10q.htm   iXBRL 10-Q 1561969
2 EX-31.1 sbbp-20210630xex31d1.htm EX-31.1 11886
3 EX-31.2 sbbp-20210630xex31d2.htm EX-31.2 11925
4 EX-32.1 sbbp-20210630xex32d1.htm EX-32.1 11623
  Complete submission text file 0001558370-21-010406.txt   6065381

Data Files

Seq Description Document Type Size
5 EX-101.SCH sbbp-20210630.xsd EX-101.SCH 48574
6 EX-101.CAL sbbp-20210630_cal.xml EX-101.CAL 46530
7 EX-101.DEF sbbp-20210630_def.xml EX-101.DEF 144026
8 EX-101.LAB sbbp-20210630_lab.xml EX-101.LAB 457728
9 EX-101.PRE sbbp-20210630_pre.xml EX-101.PRE 313651
10 EXTRACTED XBRL INSTANCE DOCUMENT sbbp-20210630x10q_htm.xml XML 970583
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 211146409
SIC: 2834 Pharmaceutical Preparations